Matches in SemOpenAlex for { <https://semopenalex.org/work/W2467024078> ?p ?o ?g. }
- W2467024078 endingPage "52" @default.
- W2467024078 startingPage "43" @default.
- W2467024078 abstract "The growth factor receptor/PI3K/AKT pathway is an important drug target in many cancers including Glioblastoma. AKT, a key node in the pathway, has 3 isoforms, AKT1, AKT2 and AKT3. Here we investigate their role in GBM. We find each activated, ser473 phosphorylated isoform is present in some GBMs but expression patterns vary. There is a direct relationship between human GBM patient outcome and both AKT1 and AKT2 mRNA levels, but an inverse relationship with AKT3 mRNA. Furthermore, AKT3 mRNA levels were high in a less aggressive GBM subtype. Overexpressing AKT3 improves survival in a rodent model of GBM and decreases colony forming efficiency, but not growth rate, in glioma cells. Silencing AKT3 slows cell cycle progression in one cell line and increases apoptosis in another. Our studies of AKT3 substrates indicate (1) silencing both AKT2 and AKT3 reduces GSK3 phosphorylation (2) only AKT2 silencing reduces S6 phosphorylation. Since S6 phosphorylation is a marker of mTORC1 activity this indicates that AKT2 activates mTORC1, but AKT3 does not. Our results indicate AKT isoforms have different roles and downstream substrates in GBM. Unexpectedly, they indicate AKT3 delays tumor progression. Therefore strategies that inhibit AKT3 may be unhelpful in some GBM patients." @default.
- W2467024078 created "2016-07-22" @default.
- W2467024078 creator A5014228865 @default.
- W2467024078 creator A5017074031 @default.
- W2467024078 creator A5030545293 @default.
- W2467024078 creator A5032539937 @default.
- W2467024078 creator A5036489899 @default.
- W2467024078 creator A5060308602 @default.
- W2467024078 creator A5066206589 @default.
- W2467024078 creator A5067130509 @default.
- W2467024078 creator A5069748676 @default.
- W2467024078 creator A5077809564 @default.
- W2467024078 creator A5079138935 @default.
- W2467024078 creator A5082911672 @default.
- W2467024078 date "2016-07-15" @default.
- W2467024078 modified "2023-10-15" @default.
- W2467024078 title "The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression" @default.
- W2467024078 cites W151714794 @default.
- W2467024078 cites W1735040307 @default.
- W2467024078 cites W1744787291 @default.
- W2467024078 cites W1970650210 @default.
- W2467024078 cites W1977534471 @default.
- W2467024078 cites W1980050623 @default.
- W2467024078 cites W1984621921 @default.
- W2467024078 cites W1995432220 @default.
- W2467024078 cites W2013482405 @default.
- W2467024078 cites W2016910640 @default.
- W2467024078 cites W2019077971 @default.
- W2467024078 cites W2025935049 @default.
- W2467024078 cites W2037207588 @default.
- W2467024078 cites W2053073281 @default.
- W2467024078 cites W2055649861 @default.
- W2467024078 cites W2064242629 @default.
- W2467024078 cites W2079701909 @default.
- W2467024078 cites W2081475812 @default.
- W2467024078 cites W2086107539 @default.
- W2467024078 cites W2093345318 @default.
- W2467024078 cites W2105150451 @default.
- W2467024078 cites W2105528101 @default.
- W2467024078 cites W2112785522 @default.
- W2467024078 cites W2113118283 @default.
- W2467024078 cites W2113377982 @default.
- W2467024078 cites W2113942802 @default.
- W2467024078 cites W2125539642 @default.
- W2467024078 cites W2126483046 @default.
- W2467024078 cites W2127063807 @default.
- W2467024078 cites W2129585918 @default.
- W2467024078 cites W2131426434 @default.
- W2467024078 cites W2140301591 @default.
- W2467024078 cites W2140439371 @default.
- W2467024078 cites W2144801963 @default.
- W2467024078 cites W2146157811 @default.
- W2467024078 cites W2148894332 @default.
- W2467024078 cites W2154336684 @default.
- W2467024078 cites W2157313196 @default.
- W2467024078 cites W2161289668 @default.
- W2467024078 cites W2162409477 @default.
- W2467024078 cites W2163986236 @default.
- W2467024078 cites W2165383481 @default.
- W2467024078 cites W2171203591 @default.
- W2467024078 doi "https://doi.org/10.1007/s11060-016-2220-z" @default.
- W2467024078 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5071179" @default.
- W2467024078 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27422127" @default.
- W2467024078 hasPublicationYear "2016" @default.
- W2467024078 type Work @default.
- W2467024078 sameAs 2467024078 @default.
- W2467024078 citedByCount "23" @default.
- W2467024078 countsByYear W24670240782017 @default.
- W2467024078 countsByYear W24670240782018 @default.
- W2467024078 countsByYear W24670240782019 @default.
- W2467024078 countsByYear W24670240782020 @default.
- W2467024078 countsByYear W24670240782021 @default.
- W2467024078 countsByYear W24670240782023 @default.
- W2467024078 crossrefType "journal-article" @default.
- W2467024078 hasAuthorship W2467024078A5014228865 @default.
- W2467024078 hasAuthorship W2467024078A5017074031 @default.
- W2467024078 hasAuthorship W2467024078A5030545293 @default.
- W2467024078 hasAuthorship W2467024078A5032539937 @default.
- W2467024078 hasAuthorship W2467024078A5036489899 @default.
- W2467024078 hasAuthorship W2467024078A5060308602 @default.
- W2467024078 hasAuthorship W2467024078A5066206589 @default.
- W2467024078 hasAuthorship W2467024078A5067130509 @default.
- W2467024078 hasAuthorship W2467024078A5069748676 @default.
- W2467024078 hasAuthorship W2467024078A5077809564 @default.
- W2467024078 hasAuthorship W2467024078A5079138935 @default.
- W2467024078 hasAuthorship W2467024078A5082911672 @default.
- W2467024078 hasBestOaLocation W24670240782 @default.
- W2467024078 hasConcept C104317684 @default.
- W2467024078 hasConcept C119056186 @default.
- W2467024078 hasConcept C11960822 @default.
- W2467024078 hasConcept C154137905 @default.
- W2467024078 hasConcept C154779307 @default.
- W2467024078 hasConcept C502942594 @default.
- W2467024078 hasConcept C55493867 @default.
- W2467024078 hasConcept C62478195 @default.
- W2467024078 hasConcept C75217442 @default.
- W2467024078 hasConcept C86554907 @default.
- W2467024078 hasConcept C86803240 @default.